Breakthrough device status for rapid, Point-of-Need molecular diagnostic platform will fill critical gap in early-stage detection of Borrelia bacteria, the cause of Lyme diseaseParis, France, January ...
Orchestra BioMed Holdings, Inc. announced significant regulatory advancements and financial results for the first quarter of 2025, including the recipient of FDA Breakthrough Device Designation for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results